Isonicotinic Acid Hydrazide in Pulmonary Tuberculosis

A total of 1600 patients suffering from depression and anxiety was treated in one consultant practice over an 8-year period. In most cases, the depressive component was treated by monoamine oxidase inhibitors, but oxazepam was used as the anxiolytic in all cases in the series. Patients were encouraged to regulate their own dosage of oxazepam, and no difficulties occurred with this technique. The results showed the overall effectiveness of oxazepam as an anxiolytic to be better than 87% in those cases where depression co-existed.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Isonicotinic Acid Hydrazide in Pulmonary Tuberculosis

Cited by 2 publications

References 5 publications

Isoniazid and P.A.S. In Chronic Pulmonary Tuberculosis a Warning

Isoniazid and P.A.S. In Chronic Pulmonary Tuberculosis a Warning

Oxazepam in the treatment of anxiety associated with depression: results of treatment in 1600 cases (Studies in depression, VI)

Contact Info

Product

Resources

About